blog
Skip to main content
Your shopping cart is empty
Your Cart is Empty

Please note that this website is a separate website than the UHMS website. Your login credentials for the UHMS website will not work here. If you have not created an account on this website yet, please do so by clicking the "Log in" button and then "Register" at the bottom of the pop-up dialog.

2021 UHMS Annual Scientific Virtual Meeting - Day 3

UHMS 2021 Virtual Annual Scientific Meeting Day 3(As presented June 12, 2021)Overall Goal of the UHMS Annual Scientific Meeting The UHMS Annual Scientific Meeting's primary goal is to provide a forum for professional scientific growth and development of the participants to improve knowledge and co ...Read more
$135.00


  • Course Description
  • Course Credits

UHMS 2021 Virtual Annual Scientific Meeting Day 3
(As presented June 12, 2021)

Overall Goal of the UHMS Annual Scientific Meeting

The UHMS Annual Scientific Meeting's primary goal is to provide a forum for professional scientific growth and development of the participants to improve knowledge and competence in order to further patient outcomes. The meeting provides a basis for exchange of ideas, both scientific and practical, among physicians, researchers, and other health care professionals. The UHMS Annual Scientific Meeting consists of abstract and poster presentations, plenary sessions, the annual Kindwall and Lambertsen lectures.

Estimated time to complete this activity: 6 hours

Termination Date: January 20, 2025 or sooner if material becomes out of date after annual reviews.

Price per day:

 

  • Non-Member: $135.00
  • UHMS Member: Regular: $105.00
  • UHMS Member: Associate: $75.00
  • UHMS Member: NBDHMT Category ‘a’ Credit Only Rate: $37.50

 

 

SATURDAY, JUNE 12

Plenary: UHM Fellow: Top articles in Hyperbaric Medicine

Kristi Ray, DO

(LSU Fellow)

Plenary: UHM Fellow: Top articles in Undersea Medicine

Chris Winstead-Derlega, MD

(Duke Fellow)

Plenary: White Paper: Lack of Emerging 24/7 Chambers

Richard Moon, MD
Frank Butler, MD

Plenary: Lessons learned from the UHMS accreditation process during COVID

David Charash, DO

Derall Garrett, CHT

Monica Skarban, RN

E1: Evaluation of the Zoll Z-Vent for use in a multiplace hyperbaric chamber

Marc Pullis, CHT

E10: Functional characteristics of the Zoll Z-Ventilator during hyperbaric exposures

Sarah M Raleigh, MD

E2: Environmental cultures of hyperbaric chambers and treatment areas

Kayla Deru

E3: A survey of hyperbaric chamber cleaning practices

Michelle Fitts

B18: Fluorescent Microangiography for Frostbite Assessment: a Case Series

Sarah M Raleigh, MD

D5: Modification of thermoregulation during cold water immersion by normobaric hypoxia

Jason M. Keeler, PhD

D19: Diving Deep: A 40 Year Prospective on the Treatment Decompression Illness in the Gulf of Mexico

Kristi Ray, DO

E11: Implementation of a successful COVID-19 screening protocol in routine and emergency operations of a multiplace hyperbaric chamber

Tiffany Castellano, MD

D6: Clinical Trial of Sildenafil to Prevent Swimming-Induced Pulmonary Edema (SIPE)

Tim Beck

F1: DIY HBO2

Marc Robins, DO

F2: Monoplace hyperbaric chamber treatment of arterial gas embolism with cardiac pacing, swan-ganz monitoring and inhaled epoprostenol

Lindell Weaver, MD

F3: HBO for Cranial Free Flap with Cook-Swartz Doppler Flow Probe DP-SDP001 to monitor arterial anastomosis flow.

Geoff Zbitnew MD

F4: Hyperbaric oxygen as adjunctive therapeutic in management of severe odontogenic fascial space infections: Case report and treatment protocol

Drew Perkins, MD

F5: Symptom reporting during intentional carbon monoxide poisoning

Lindell Weaver, MD

F6: Ozone therapy gas embolism treated with HBO2

Marc Robins, DO


CONTINUING EDUCATION (If you attended this meeting via live stream on June 12th, you will not be eligible for continuing education credit again):

 

Designation Statements:

Physician CME: The Undersea and Hyperbaric Medical Society designates this enduring material for a maximum of 6.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing CEU: Approved license types: Advanced Registered Nurse Practitioner; Clinical Nurse Specialist; Licensed Practical Nurse; Registered Nurse; Certified Nursing Assistant; Respiratory Care Practitioner Critical Care; Respiratory Care Practitioner Non-Critical Care; Registered Respiratory Therapist; Certified Respiratory Therapist. This enduring material is approved for 6.00 contact hours by the Florida Board of Registered Nursing Provider #50-10881.

NBDHMT: This enduring material is approved for 3.50 Category A credit hours by National Board of Diving and Hyperbaric Medical Technology, 9 Medical Park, Suite 440, Columbia, South Carolina 29203.

o NBDHMT Accreditation Statement: For CHT recertification purposes, the NBDHMT requires a minimum of nine of the minimum 12 required Category A credits relate directly to any combination of hyperbaric operations, related technical aspects and chamber safety.

Accreditation Statement: The Undersea and Hyperbaric Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

Disclaimer: The information provided at this CME activity is for Continuing Medical Education purposes only. The lecture content, statements or opinions expressed however, do not necessarily represent those of the Undersea and Hyperbaric Medical Society.

 

Full Disclosure Statement: All faculty members and planners participating in continuing medical education activities sponsored by Undersea and Hyperbaric Medical Society are expected to disclose to the participants any relevant financial relationships with ineligible companies. Full disclosure of faculty and planner relevant financial relationships will be made at the activity. 

 

Disclosure:

No individuals in control of content (planners/faculty/reviewers/authors) for this educational activity have relevant financial relationship(s) to disclose with ineligible companies, whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

No commercial support was received for this activity.

 

 

 

6.0
6.0
3.5